Zobrazeno 1 - 1
of 1
pro vyhledávání: '"PRNT50, maximum dilution with greater than 50% inhibition"'
Autor:
Andrea R Delpero, Larry Karnes, Shannon E. Ronca, Shashikant Nagre, David G. Alleva, Sarah S Webb, Hanne Andersen Elyard, Allison I Jasa, Thomas M. Lancaster, JoAnn Yee, Sylaja Murikipudi, Vidhya Rao, Frans Sollie, Nishit J Shah, Freedom M Green, Melanie M Scully, Jeffrey R Haworth, Thillainaygam Sathiyaseelan, Emma K Greaves, Ramya Ragupathy, Jeffrey Klein, Todd C. Zion
Publikováno v:
Vaccine
AKS-452 is a biologically-engineered vaccine comprising an Fc fusion protein of the SARS-CoV-2 viral spike protein receptor binding domain antigen (Ag) and human IgG1 Fc (SP/RBD-Fc) in clinical development for the induction and augmentation of neutra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fbd52d976e8f0e684d66cd171ccbc43
https://doi.org/10.1016/j.vaccine.2021.09.077
https://doi.org/10.1016/j.vaccine.2021.09.077
